• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 2009

View Archived Issues

Novel ligand-directed toxin EGF4KDEL 7mut shows promise in preclinical cancer models

Read More

Shire reports results from third quarter of 2009

Read More

Phase III data support benefit of mipomersen in homozygous familiar hypercholesterolemia

Read More

Aleglitazar has no clinically relevant interactions with statins in healthy subjects

Read More

Opioid-nornicotine co-drugs described by the University of Kentucky

Read More

CytRx to initiate phase II INNO-206 trial in patients with soft tissue sarcomas

Read More

Cytopia begins enrollment in phase I/II trial of CYT-387 in myelofibrosis

Read More

Clinical data support safety of mepolizumab in pediatric eosinophilic esophagitis

Read More

Gilead Sciences and GSK sign licensing agreement to commercialize Viread for HBV in Asia

Read More

Novel dipeptidyl peptidase-IV inhibitors in early development at Sun Pharma

Read More

FDA reviews preliminary data from SCOUT safety study of Meridia

Read More

Cylene Pharmaceuticals claims novel protein kinase inhibitors for cancer treatment

Read More

Nycomed discovers PDE5A inhibitors for the treatment of asthma

Read More

Actelion claims P2Y12 receptor antagonists

Read More

Transcept to meet with FDA to discuss complete response letter on Intermezzo for insomnia

Read More

Accelerate Brain Cancer Cure awards grant to Tocagen to develop treatment for recurrent GBM

Read More

Proteon begins phase I/II trial of PRT-201 for improvement of vascular access in ESRD

Read More

Ipsen initiates phase II trial of BN-83495 in endometrial cancer

Read More

FDA accepts for review Eisai's Aricept NDA for moderate to severe AD

Read More

Preclinical characterization of PKI-402 disclosed at AACR-NCI-EORTC meeting

Read More

Correlation between high TNFalpha levels and tumor susceptibility to LCL-161

Read More

Aegera Therapeutics begins phase IIb AEG-35156 study in acute myeloid leukemia

Read More

Astex Therapeutics' AT-9283 is granted orphan drug status in AML in U.S. and Europe

Read More

Human Genome Sciences submits BLA to FDA for Zalbin to treat hepatitis C

Read More

Merck & Co. and Idera extend research collaboration on TLR agonist vaccine adjuvants

Read More

Agensys and Seattle Genetics expand antibody-drug conjugate collaboration

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 11, 2025.
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • AI-generated illustration of heart and metabolic impact

    Deep Apple signs big Novo deal for cardiometabolic small molecules

    BioWorld
    Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe